Meds Apotek AB (STO:MEDS)
24.80
-0.60 (-2.36%)
At close: Jul 23, 2026
Meds Apotek AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 66.66 | 45.17 | 21.17 | 50.59 | 24.7 |
Cash & Short-Term Investments | 66.66 | 45.17 | 21.17 | 50.59 | 24.7 |
Cash Growth | 350.16% | 113.38% | -58.16% | 104.80% | - |
Accounts Receivable | 24.48 | 25.76 | 24.01 | 14.95 | 14.7 |
Other Receivables | 7.04 | 9.13 | 4.7 | 0.57 | 3.3 |
Total Trade Receivables | 31.52 | 34.89 | 28.72 | 15.52 | 18 |
Inventory | 128.84 | 144.17 | 102.27 | 81.76 | 66.6 |
Other Current Assets | 6.71 | 5.3 | 4.73 | 3.53 | 1.9 |
Total Current Assets | 233.73 | 229.53 | 156.88 | 151.39 | 111.3 |
Net Property, Plant & Equipment | 17.44 | 17.65 | 36.1 | 46.49 | 54.7 |
Other Intangible Assets | 11.97 | 12.27 | 14.55 | 18.07 | 20.1 |
Long-Term Investments | 0.97 | 0.79 | 0.43 | 0.13 | 0 |
Other Long-Term Assets | 10.4 | 10.46 | 0.2 | 0.22 | 0.2 |
Total Assets | 274.51 | 270.7 | 208.16 | 216.31 | 186.3 |
Accounts Payable | 103.36 | 114.11 | 103.84 | 58.41 | 65.4 |
Accrued Expenses | 25.83 | 17.09 | 18.52 | 16.74 | 14.7 |
Current Portion of Long-Term Debt | - | - | - | 6.41 | 0 |
Current Portion of Leases | 2.38 | 7.05 | 8.37 | 9.76 | 7.7 |
Other Current Liabilities | 1.76 | 2.41 | 1.47 | 5.87 | 2.6 |
Total Current Liabilities | 133.33 | 140.66 | 132.2 | 97.19 | 90.5 |
Long-Term Debt | - | - | - | 23.33 | 0 |
Long-Term Leases | - | - | 15.72 | 25.41 | 31.1 |
Other Long-Term Liabilities | 1.86 | 1.65 | 1.57 | 2 | 2.3 |
Total Long-Term Liabilities | 1.86 | 1.65 | 17.28 | 50.74 | 33.4 |
Total Liabilities | 135.2 | 142.31 | 149.48 | 147.93 | 123.9 |
Common Stock | 0.74 | 0.74 | 0.69 | 0.69 | 0.6 |
Additional Paid-in Capital | 609.82 | 609.84 | 547.91 | 546.62 | 489.5 |
Retained Earnings | -471.25 | -482.19 | -489.91 | -478.92 | -427.8 |
Shareholders' Equity | 139.31 | 128.4 | 58.68 | 68.39 | 62.3 |
Total Liabilities & Equity | 274.51 | 270.7 | 208.16 | 216.31 | 186.3 |
Total Debt | 2.38 | 7.05 | 24.08 | 64.91 | 38.8 |
Net Cash (Debt) | 64.28 | 38.12 | -2.92 | -14.33 | -14.1 |
Net Cash Growth | 68.62% | - | - | - | - |
Net Cash Per Share | 3.44 | 2.14 | -0.17 | -0.85 | -0.92 |
Book Value | 139.31 | 128.4 | 58.68 | 68.39 | 62.3 |
Book Value Per Share | 7.45 | 7.20 | 3.40 | 4.08 | 4.06 |
Tangible Book Value | 127.34 | 116.13 | 44.13 | 50.32 | 42.2 |
Tangible Book Value Per Share | 6.81 | 6.51 | 2.56 | 3.00 | 2.75 |